Abstract
Amyotrophic lateral sclerosis (ALS), a specific neurodegenerative disease, imposed increased economic and utilizations burden on the healthcare system, especially with the progress of the diseases severity. However, the economic burden on Chinese ALS patients remained unclear. This study therefore was aimed to investigate medical cost and healthcare utilization for Chinese ALS patients.Longitudinal health data of over 20 million individuals, including military personnel and civilians, was collected from all Chinese military hospitals. We identified 480 patients with a first major diagnosis for ALS from 2015 to 2018, while matched 400 controlled patients on age, gender, ethnic group, geographic region, length of stay, year of diagnosis and comorbidity. Their medical cost and healthcare utilizations were then measured 1 year before, and 1 year after ALS diagnosis.The median annual medical cost of ALS patients was about 2-fold higher, 17,087 CNY during the index year than 1 year before, 7859 CNY. The highest increase in utilizations may account for medical costs on ALS patients, which was represented by hospitalizations (Odd Ratio (OR) = 4.26, 95% confidence interval (CI) 3.52, 5.15), electromyography (OR = 4.14, 95% CI 2.37, 7.22...Continue Reading
References
Oct 1, 1996·Neurology·L M Klein, D A Forshew
Jan 14, 2000·Archives of Neurology·B J TraynorO Hardiman
Sep 26, 2000·Muscle & Nerve·J R Daube
Oct 13, 2011·Nature Reviews. Neurology·Orla HardimanMatthew C Kiernan
Dec 16, 2011·Clinical Neurology and Neurosurgery·Eleonora CelluraVincenzo La Bella
Mar 26, 2013·PM & R : the Journal of Injury, Function, and Rehabilitation·Nanette C Joyce, Gregory T Carter
Jul 4, 2013·Acta Neurologica Scandinavica·M S LiuUNKNOWN Chinese ALS Association
Jul 10, 2013·Muscle & Nerve·Jane LarkindaleValerie A Cwik
Jul 19, 2013·Neuroepidemiology·A ChiòL A White
Jul 6, 2014·BioMed Research International·Laura Robelin, Jose Luis Gonzalez De Aguilar
Jul 16, 2014·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Matthew GladmanLorne Zinman
Oct 7, 2014·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Sheelah ConnollyOrla Hardiman
May 1, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Matthew Gladman, Lorne Zinman
Jul 1, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Lu ChenDongsheng Fan
Aug 12, 2016·Nature Communications·Karissa C ArthurBryan J Traynor
Jul 13, 2017·The New England Journal of Medicine·Robert H Brown, Ammar Al-Chalabi
Sep 12, 2017·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Lisa MengJinsy Andrews
Feb 3, 2018·Journal of Neurology·Angela RosenbohmUNKNOWN ALS Registry Swabia Study Group
Mar 5, 2018·Brain Research·Xiaolu LiuDongsheng Fan
Nov 24, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Jie LiuKexu Sui
Mar 30, 2019·Journal of Neurology·Johannes DorstAlbert C Ludolph
Aug 29, 2019·BMC Public Health·Han SongJing-Yuan Chen